<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://ipharmag.com/article/braveheart-cardiac-myosin-hcm-ipo</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T08:51:00+00:00</news:publication_date>
      <news:title>Braveheart Bio Raises $382M in IPO for a China-Licensed Heart Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/dronabinol-thc-ptsd-nightmares-trial</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T08:51:00+00:00</news:publication_date>
      <news:title>A Cannabis-Derived Drug Ended PTSD Nightmares for Over a Third of Patients in a Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/moderna-mrna-flu-vaccine-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T08:51:00+00:00</news:publication_date>
      <news:title>FDA Approves Moderna&amp;rsquo;s mFlusiva, the First mRNA Flu Vaccine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/novo-nordisk-large-ma-strategy-pipeline</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T08:51:00+00:00</news:publication_date>
      <news:title>Novo Nordisk Rules Out Big M&amp;amp;A for Now as It Works to Steady Its Pipeline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/covid-reactivates-dormant-viruses-long-covid</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T08:51:00+00:00</news:publication_date>
      <news:title>Severe COVID Can Reawaken Dormant Viruses, Offering a New Clue to Long COVID</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/recursion-genentech-ai-neuro-target</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05T14:12:26+00:00</news:publication_date>
      <news:title>Recursion and Genentech Validate Their First AI-Discovered Neuroscience Target</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/quanthealth-ai-simulate-clinical-trials</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05T14:12:26+00:00</news:publication_date>
      <news:title>QuantHealth Raises $45M to Simulate Clinical Trials Before Real Patients Enroll</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/expedition-therapeutics-copd-dpp1-funding</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05T14:12:26+00:00</news:publication_date>
      <news:title>Expedition Raises $115M for a China-Licensed COPD Pill Targeting Inflammation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/kindred-crispr-hypoallergenic-dogs-can-f1</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05T14:12:26+00:00</news:publication_date>
      <news:title>Startup Uses CRISPR to Breed Beagle Pups Free of the Main Dog Allergen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/stanford-ruptoblasts-exploding-immune-cells</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05T14:12:26+00:00</news:publication_date>
      <news:title>Scientists Discover Immune Cells That Explode Like Tiny Bombs to Kill Invaders</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/pfizer-expands-cost-cutting-plan-2026</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-04T19:39:28+00:00</news:publication_date>
      <news:title>Pfizer Deepens Cost Cuts Toward $6.7 Billion as Pandemic Revenue Fades</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/hpv-chewing-gum-oral-cancer-prevention</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-04T19:39:28+00:00</news:publication_date>
      <news:title>A Bean-Based Chewing Gum Cut Oral HPV by Up to 93% in Lab Tests</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/ai-brain-aging-maps-mri-neurodegeneration</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-04T19:39:28+00:00</news:publication_date>
      <news:title>AI Turns Brain MRIs Into Region-by-Region &amp;lsquo;Aging Maps&amp;rsquo; to Study Dementia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/vertex-sionna-cystic-fibrosis-competition</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-04T19:39:28+00:00</news:publication_date>
      <news:title>Vertex Beats Estimates, but a Rival 50 Times Smaller Looms Over Its Cystic Fibrosis Empire</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/fda-breakthrough-olomorasib-pancreatic-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-04T19:39:28+00:00</news:publication_date>
      <news:title>FDA Grants Breakthrough Status to Lilly&amp;rsquo;s Olomorasib in KRAS-Mutant Pancreatic Cancer</news:title>
    </news:news>
  </url>
</urlset>
